The Covid-19 vaccine Convidecia received its emergency approval on Thursday from the World Health Organization.

It was designed by CanSino Biologics laboratories, and hits the market as Beijing battles a resurgence of the pandemic.

This vaccine is based on a modified human adenovirus, it is administered in a single dose and the WHO recommends it for all age groups from 18 years old, specifies a press release from the WHO.

World

Covid-19 in China: Shanghai announces zero cases of coronavirus but remains in containment

World

North Korea: Eight new deaths from Covid-19, Kim Jong-un castigates health authorities

  • Health

  • Coronavirus

  • Covid vaccine

  • China